Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer

Abstract excerpt

Given the very substantial heterogeneity of most human cancers, it is likely that most cancer therapeutics will be active in only a small fraction of any population of patients. As such, the development of new therapeutics, coupled with methods to match a therapy with the individual patient, will be critical to achieving significant gains in disease outcome. One such opportunity is the use of expression...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bioinformatics and Genomic Networks
• Share to Cancer Cells and Metastasis
• Share to Computational Drug Discovery Methods